Dev Institute Of Nuclear Medicine Private Limited - Company Profile

It is a healthcare private limited company based in Patna, Bihar, India, established in 2004.
2004 Patna, Bihar, India Active
Last Updated:
Access Report
About Dev Institute Of Nuclear Medicine Private Limited

Dev Institute Of Nuclear Medicine Private Limited, a active private limited company, was established on 08 April 2004 in Patna, Bihar, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U85110BR2004PTC010679. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.27 Cr.

It upholds a compliant status. Employing 11 professional, Its leadership includes Bipin Kumar Srivastava (Director), Vihag Raman (Director), Girish Kumar Srivastava (Director). Past directors included Ajit Kumar Das, Devendra Narayan Singh, Anupama Kashyap. It holds ₹12.85 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No.-96B,Road No.-2,Rajendra Nagar, Patna-16., Patna, Bihar, 800016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110BR2004PTC010679

  • Registration Number

    010679

  • Incorporation Date

    08 April 2004

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.27 Cr

  • ROC Code

    Roc Patna

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.27 Cr
  • Company Age 21 Year, 10 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 12.85 Cr
  • Revenue Growth **** -2.08%
  • Profit Growth **** 1.47%
  • Ebitda **** -8.17%
  • Net Worth 24.37%
  • Total Assets **** 6.54%
Company report

Dev Institute Of Nuclear Medicine Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dev Institute Of Nuclear Medicine Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dev Institute Of Nuclear Medicine Private Limited?
Current Directors
Name Designation Appointment Date Status
Bipin Kumar Srivastava Director 12 Apr 2015 Current
Vihag Raman Director 12 Apr 2015 Current
Girish Kumar Srivastava Director 20 Apr 2021 Current
Sangeeta Srivastva Director 08 Apr 2004 Current
Ravi Shankar Kumar Director 15 Jan 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Jul 2015 Past
Pramod Abcsdd Director 17 Feb 2018 Past
Pramod Abcsdd Director 12 Jan 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dev Institute Of Nuclear Medicine.

Dev Institute Of Nuclear Medicine Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.08% decrease. The company also saw a slight improvement in profitability, with a 1.47% increase in profit. The company's net worth Soared by an impressive increase of 24.37%.

Dev Institute Of Nuclear Medicine revenue growth over time
Dev Institute Of Nuclear Medicine profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.08%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.35%
*******
*******
*******
*******
Total Assets
*******
 6.54%
*******
*******
*******
*******
Profit or Loss
*******
 1.47%
*******
*******
*******
*******
Net Worth
*******
 24.37%
*******
*******
*******
*******
EBITDA
*******
 -8.17%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dev Institute Of Nuclear Medicine?

In 2021, Dev Institute Of Nuclear Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹128,549,351.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 4.94 Cr
  • Hdfc Bank Limited : 3.49 Cr
  • Siemens Financial Services Private Limited : 3.47 Cr
  • Bank Of Baroda : 0.65 Cr
  • India Infoline Finance Limited : 0.29 Cr
Latest Charge Details
Date Lender Amount Status
26 Mar 2024 Others ₹4.43 M Open
31 Dec 2022 Hdfc Bank Limited ₹2.50 M Open
26 Jun 2019 Others ₹4.50 Cr Open
12 Feb 2016 Hdfc Bank Limited ₹3.24 Cr Open
30 Mar 2015 India Infoline Finance Limited ₹2.94 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Dev Institute Of Nuclear Medicine?

Dev Institute Of Nuclear Medicine has a workforce of 11 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dev Institute Of Nuclear Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dev Institute Of Nuclear Medicine's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dev Institute Of Nuclear Medicine
Recent Activity within the Organization
  • Charges

    A charge with Others amounted to Rs. 0.44 Cr with Charge ID 100897511 was registered on 26 Mar 2024. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100668491 was registered on 31 Dec 2022. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 3.24 Cr registered on 12 Feb 2016 with Charge ID 100021652 was modified on 18 Apr 2022. was documented.

  • Annual General Meeting

    The activity Dev Institute Of Nuclear Medicine Private Limited last Annual general meeting of members was held on 31 Dec 2021 as per latest MCA records. was completed.

  • Director Appointment

    Girish Kumar Srivastava was appointed as a Director was appointed as a Director on 20 Apr 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Balance Sheet

    Dev Institute Of Nuclear Medicine Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Patna. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dev Institute Of Nuclear Medicine Private Limited?

The CIN of Dev Institute Of Nuclear Medicine Private Limited is U85110BR2004PTC010679.

Where is Dev Institute Of Nuclear Medicine Private Limited headquartered?

Dev Institute Of Nuclear Medicine Private Limited is headquartered at Plot No.-96B,Road No.-2,Rajendra Nagar, Patna-16., Patna, Bihar, 800016.

When was Dev Institute Of Nuclear Medicine Private Limited incorporated?

Dev Institute Of Nuclear Medicine Private Limited was incorporated on 08 April 2004.

Who are the current directors of Dev Institute Of Nuclear Medicine Private Limited?

The current directors of Dev Institute Of Nuclear Medicine Private Limited are

What is the primary industry of Dev Institute Of Nuclear Medicine Private Limited?

The primary industry of Dev Institute Of Nuclear Medicine Private Limited is Hospital And Medical Care.

Is Dev Institute Of Nuclear Medicine Private Limited a listed company?

Dev Institute Of Nuclear Medicine Private Limited is unlisted.

What is the capital structure of Dev Institute Of Nuclear Medicine Private Limited?

The authorized capital of Dev Institute Of Nuclear Medicine Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.27 Cr.

What is the compliance status of Dev Institute Of Nuclear Medicine Private Limited?

The compliance status of Dev Institute Of Nuclear Medicine Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available